Solu Therapeutics
PrivateLast Round
Series A
Apr 9, 2025
Total Funding Raised
$72M
Company Overview
Solu Therapeutics is a biotechnology company that develops a cytotoxicity-targeting chimera platform designed to eliminate disease-driving cells, providing oncology therapeutics that help reduce the risk of inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solu Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Solu Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2025 | ||||
| Seed | Aug 1, 2023 |
Key People
Founding team and executive leadership
Solu Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A. M. Pappas & Associates | Series A |
| DCVC Bio | Series A, Seed |
| Santé Ventures | Series A |
| Alexandria Venture Investments | Series A |
| Astellas Venture Management | Series A, Seed |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Series A |
| Longwood Fund | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2025
Enda Moran appointed as the new Chief Operating Officer.
- Apr 9, 2025
$41M Series A round completed.
Solu Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Solu Therapeutics's valuation, stock price, and market status.
